Atlas Trials

Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction

Clinical trial NCT05159284 · UNKNOWN

Trial details

NCT number
NCT05159284
Sponsor
Laboratorios Thea, Spain
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Dry EyeMeibomian Gland Dysfunction
Start date
2021-11-09
Primary completion
2024-12-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.